John Hamill

Insider Reports History

Location
Furlong, PA
Signature
/s/ John Hamill
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Hamill:

Company Role Class Num Shares Value Price $ Report Date Ownership
WINDTREE THERAPEUTICS INC /DE/ SVP & CFO Common Stock 72,800 $74,249 $1.02 26 Jul 2022 Direct
Aprea Therapeutics, Inc. SrVP/CFO/Prin Fin & Acct Ofcr Common Stock 27,733 $32,308 $1.16 10 Dec 2025 Direct
Aprea Therapeutics, Inc. SrVP/CFO/Prin Fin & Acct Ofcr Stock Options (Right to Buy) 13,460 27 Mar 2025 Direct
Aprea Therapeutics, Inc. SrVP/CFO/Prin Fin & Acct Ofcr Common Warrant 5,000 10 Dec 2025 Direct

Insider Reports Filed by John Hamill

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APRE Aprea Therapeutics, Inc. 10 Dec 2025 2 +$5,825 4 SrVP/CFO/Prin Fin & Acct Ofcr 11 Dec 2025, 08:31
APRE Aprea Therapeutics, Inc. 27 Mar 2025 2 $0 4 SrVP/CFO/Prin Fin & Acct Ofcr 31 Mar 2025, 16:31
APRE Aprea Therapeutics, Inc. 11 Oct 2024 1 +$123 4 SrVP/CFO/Prin Fin & Acct Ofcr 16 Oct 2024, 08:30
APRE Aprea Therapeutics, Inc. 10 Oct 2024 1 +$1,174 4 SrVP/CFO/Prin Fin & Acct Ofcr 15 Oct 2024, 08:30
APRE Aprea Therapeutics, Inc. 28 Mar 2024 2 $0 4 SrVP/CFO/Prin Fin & Acct Ofcr 28 Mar 2024, 17:59
APRE Aprea Therapeutics, Inc. 13 Mar 2024 3 +$7,363 4 SrVP/CFO/Prin Fin & Acct Ofcr 14 Mar 2024, 20:54
APRE Aprea Therapeutics, Inc. 27 Feb 2023 1 +$5,250 4 SrVP/CFO/Prin Fin & Acct Ofcr 27 Feb 2023, 17:37
APRE Aprea Therapeutics, Inc. 30 Jan 2023 2 $0 4 SrVP/CFO/Prin. Fin&Acctg. Off 30 Jan 2023, 16:21
APRE Aprea Therapeutics, Inc. 30 Jan 2023 0 $0 3 SrVP/CFO/Prin. Fin &Acctg. Off 30 Jan 2023, 16:19
WINT WINDTREE THERAPEUTICS INC /DE/ 26 Jul 2022 1 +$1,100 4 SVP & CFO 26 Jul 2022, 16:38
WINT WINDTREE THERAPEUTICS INC /DE/ 04 Mar 2022 2 $0 4 SVP & CFO 07 Mar 2022, 16:52